- Home
- ENTA vs SPIR Comparison
ENTA vs SPIR Comparison
Compare ENTA & SPIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENTA
- SPIR
- Stock Information
- Founded
- ENTA 1995
- SPIR 2012
- Country
- ENTA United States
- SPIR United States
- Employees
- ENTA N/A
- SPIR N/A
- Industry
- ENTA Biotechnology: Pharmaceutical Preparations
- SPIR Telecommunications Equipment
- Sector
- ENTA Health Care
- SPIR Consumer Discretionary
- Exchange
- ENTA Nasdaq
- SPIR Nasdaq
- Market Cap
- ENTA 212.9M
- SPIR 238.3M
- IPO Year
- ENTA 2013
- SPIR N/A
- Fundamental
- Price
- ENTA $12.28
- SPIR $9.70
- Analyst Decision
- ENTA Buy
- SPIR Buy
- Analyst Count
- ENTA 4
- SPIR 6
- Target Price
- ENTA $20.00
- SPIR $14.20
- AVG Volume (30 Days)
- ENTA 194.5K
- SPIR 195.2K
- Earning Date
- ENTA 11-25-2024
- SPIR 11-06-2024
- Dividend Yield
- ENTA N/A
- SPIR N/A
- EPS Growth
- ENTA N/A
- SPIR N/A
- EPS
- ENTA N/A
- SPIR N/A
- Revenue
- ENTA $71,960,000.00
- SPIR $107,223,000.00
- Revenue This Year
- ENTA N/A
- SPIR $18.74
- Revenue Next Year
- ENTA $5.14
- SPIR $23.69
- P/E Ratio
- ENTA N/A
- SPIR N/A
- Revenue Growth
- ENTA N/A
- SPIR 24.15
- 52 Week Low
- ENTA $8.08
- SPIR $3.27
- 52 Week High
- ENTA $17.80
- SPIR $19.40
- Technical
- Relative Strength Index (RSI)
- ENTA 60.62
- SPIR 51.63
- Support Level
- ENTA $10.40
- SPIR $8.80
- Resistance Level
- ENTA $11.80
- SPIR $9.91
- Average True Range (ATR)
- ENTA 0.54
- SPIR 0.42
- MACD
- ENTA 0.21
- SPIR -0.02
- Stochastic Oscillator
- ENTA 99.58
- SPIR 64.29
About ENTA Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc is an American biotechnology company focused on the research and development of molecule drugs to cure viral infections and liver diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.
About SPIR Spire Global Inc.
Spire Global Inc is a provider of space-based data, analytics, and Space Services, offering datasets and powerful insights about Earth from the ultimate vantage point of space so that organizations can make decisions with confidence, accuracy, and speed. It generates revenue from four solutions: Maritime, Aviation, Weather, and Space Services. It offers the following three data solutions to customers; Maritime-precise space-based data used for accurate ship monitoring, ship safety, and route optimization, Aviation-precise space-based data used for accurate aircraft monitoring, aircraft safety, and route optimization, and Weather-precise space-based data used for accurate weather forecasting.